Tucatinib,Trastuzumab,fulvestrant
Seagen
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'tukysa', 'bcsm', 'tucatinib']
tucatinib plus trastuzumab shows activity in her2+ metastatic biliary tract cancer
#hpbcsm #cholangiocarcinoma #biliarytractcancer #bileductcancer #tucatinib #tukysa #her2 
BREAKING CHOLANGIOCARCINOMA NEWS Maintained by a
#CholangioConnect Patient Mentor, Awareness Advocate & #HopeDealer
(Stage 3A iCCA, NED 5/29/20)